97 related articles for article (PubMed ID: 16905208)
1. Molecular responses of rectal cancer to preoperative chemoradiation.
Debucquoy A; Goethals L; Geboes K; Roels S; Mc Bride WH; Haustermans K
Radiother Oncol; 2006 Aug; 80(2):172-7. PubMed ID: 16905208
[TBL] [Abstract][Full Text] [Related]
2. Lymph node status and TS gene expression are prognostic markers in stage II/III rectal cancer after neoadjuvant fluorouracil-based chemoradiotherapy.
Liersch T; Langer C; Ghadimi BM; Kulle B; Aust DE; Baretton GB; Schwabe W; Häusler P; Becker H; Jakob C
J Clin Oncol; 2006 Sep; 24(25):4062-8. PubMed ID: 16943523
[TBL] [Abstract][Full Text] [Related]
3. Prognostic and predictive value of baseline and posttreatment molecular marker expression in locally advanced rectal cancer treated with neoadjuvant chemoradiotherapy.
Bertolini F; Bengala C; Losi L; Pagano M; Iachetta F; Dealis C; Jovic G; Depenni R; Zironi S; Falchi AM; Luppi G; Conte PF
Int J Radiat Oncol Biol Phys; 2007 Aug; 68(5):1455-61. PubMed ID: 17445998
[TBL] [Abstract][Full Text] [Related]
4. Cyclooxygenase-2 expression in pretreatment biopsy as a predictor of tumor responses after preoperative chemoradiation in rectal cancer.
Min BS; Choi YJ; Pyo HR; Kim H; Seong J; Chung HC; Rha SY; Kim NK
Arch Surg; 2008 Nov; 143(11):1091-7; discussion 1097. PubMed ID: 19015468
[TBL] [Abstract][Full Text] [Related]
5. Absence of cyclooxygenase-2 protein expression is a predictor of tumor regression in rectal cancer treated with preoperative short-term chemoradiotherapy.
Kobayashi H; Hashiguchi Y; Ueno H; Shinto E; Kajiwara Y; Mochizuki H
Dis Colon Rectum; 2007 Sep; 50(9):1354-62. PubMed ID: 17308999
[TBL] [Abstract][Full Text] [Related]
6. The prognostic value of lymph node metastases and tumour regression grade in rectal cancer patients treated with long-course preoperative chemoradiotherapy.
Lindebjerg J; Spindler KL; Ploen J; Jakobsen A
Colorectal Dis; 2009 Mar; 11(3):264-9. PubMed ID: 18573119
[TBL] [Abstract][Full Text] [Related]
7. Double blind randomized phase II study with radiation+5-fluorouracil+/-celecoxib for resectable rectal cancer.
Debucquoy A; Roels S; Goethals L; Libbrecht L; Van Cutsem E; Geboes K; Penninckx F; D'Hoore A; McBride WH; Haustermans K
Radiother Oncol; 2009 Nov; 93(2):273-8. PubMed ID: 19747744
[TBL] [Abstract][Full Text] [Related]
8. [Correlation of VEGF and Ki67 expression with sensitivity to neoadjuvant chemoradiation in rectal adenocarcinoma].
Jiang SM; Wang RB; Yu JM; Zhu KL; Mu DB; Xu ZF
Zhonghua Zhong Liu Za Zhi; 2008 Aug; 30(8):602-5. PubMed ID: 19102938
[TBL] [Abstract][Full Text] [Related]
9. Predictors of tumor response and downstaging in patients who receive preoperative chemoradiation for rectal cancer.
Das P; Skibber JM; Rodriguez-Bigas MA; Feig BW; Chang GJ; Wolff RA; Eng C; Krishnan S; Janjan NA; Crane CH
Cancer; 2007 May; 109(9):1750-5. PubMed ID: 17387743
[TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of vascular endothelial growth factor and cyclooxygenase-2 in patients with rectal cancer treated with preoperative radiotherapy.
Giralt J; Navalpotro B; Hermosilla E; de Torres I; Espin E; Reyes V; Cerezo L; de las Heras M; Ramon y Cajal S; Armengol M; Benavente S
Oncology; 2006; 71(5-6):312-9. PubMed ID: 17687192
[TBL] [Abstract][Full Text] [Related]
11. Disseminated tumor cells in peripheral blood: a novel marker for therapy response in locally advanced rectal cancer patients undergoing preoperative chemoradiation.
Zitt M; Zitt M; Müller HM; Dinnewitzer AJ; Schwendinger V; Goebel G; De Vries A; Amberger A; Weiss H; Margreiter R; Ofner D; Oberwalder M
Dis Colon Rectum; 2006 Oct; 49(10):1484-91. PubMed ID: 17019657
[TBL] [Abstract][Full Text] [Related]
12. Low molecular weight heat shock protein HSP27 is a prognostic indicator in rectal cancer but not colon cancer.
Tweedle EM; Khattak I; Ang CW; Nedjadi T; Jenkins R; Park BK; Kalirai H; Dodson A; Azadeh B; Terlizzo M; Grabsch H; Mueller W; Myint S; Clark P; Wong H; Greenhalf W; Neoptolemos JP; Rooney PS; Costello E
Gut; 2010 Nov; 59(11):1501-10. PubMed ID: 20947885
[TBL] [Abstract][Full Text] [Related]
13. Pretreatment expression of 13 molecular markers as a predictor of tumor responses after neoadjuvant chemoradiation in rectal cancer.
Huh JW; Lee JH; Kim HR
Ann Surg; 2014 Mar; 259(3):508-15. PubMed ID: 23787217
[TBL] [Abstract][Full Text] [Related]
14. The role of carcinoembriogenic antigen in predicting response and survival to neoadjuvant chemoradiotherapy for distal rectal cancer.
Perez RO; São Julião GP; Habr-Gama A; Kiss D; Proscurshim I; Campos FG; Gama-Rodrigues JJ; Cecconello I
Dis Colon Rectum; 2009 Jun; 52(6):1137-43. PubMed ID: 19581858
[TBL] [Abstract][Full Text] [Related]
15. Bax, a predictive marker for therapeutic response to preoperative chemoradiotherapy in patients with rectal carcinoma.
Chang HJ; Jung KH; Kim DY; Jeong SY; Choi HS; Kim YH; Sohn DK; Yoo BC; Lim SB; Kim DH; Ahn JB; Kim IJ; Kim JM; Yoon WH; Park JG
Hum Pathol; 2005 Apr; 36(4):364-71. PubMed ID: 15891997
[TBL] [Abstract][Full Text] [Related]
16. A simplified tumor regression grade correlates with survival in locally advanced rectal carcinoma treated with neoadjuvant chemoradiotherapy.
Beddy D; Hyland JM; Winter DC; Lim C; White A; Moriarty M; Armstrong J; Fennelly D; Gibbons D; Sheahan K
Ann Surg Oncol; 2008 Dec; 15(12):3471-7. PubMed ID: 18846402
[TBL] [Abstract][Full Text] [Related]
17. Prognostic value of histologic tumor regression, thymidylate synthase, thymidine phosphorylase, and dihydropyrimidine dehydrogenase in rectal cancer UICC Stage II/III after neoadjuvant chemoradiotherapy.
Jakob C; Liersch T; Meyer W; Baretton GB; Schwabe W; Häusler P; Kulle B; Becker H; Aust DE
Am J Surg Pathol; 2006 Sep; 30(9):1169-74. PubMed ID: 16931962
[TBL] [Abstract][Full Text] [Related]
18. Molecular prognostic factors in locally irresectable rectal cancer treated preoperatively by chemo-radiotherapy.
Reerink O; Karrenbeld A; Plukker JT; Verschueren RC; Szabó BG; Sluiter WJ; Hospers GA; Mulder NH
Anticancer Res; 2004; 24(2C):1217-21. PubMed ID: 15154650
[TBL] [Abstract][Full Text] [Related]
19. Carcinoembryonic antigen as a predictor of pathologic response and a prognostic factor in locally advanced rectal cancer patients treated with preoperative chemoradiotherapy and surgery.
Park JW; Lim SB; Kim DY; Jung KH; Hong YS; Chang HJ; Choi HS; Jeong SY
Int J Radiat Oncol Biol Phys; 2009 Jul; 74(3):810-7. PubMed ID: 19101093
[TBL] [Abstract][Full Text] [Related]
20. Preoperative chemoradiotherapy with concomitant small field boost irradiation for locally advanced rectal cancer: a multi-institutional phase II study (KROG 04-01).
Kim DY; Kim TH; Jung KH; Chang HJ; Lim SB; Choi HS; Jeong SY; Nam TK; Ryu SY; Lee DS; Choi SI; Kang JH; Yoon SC
Dis Colon Rectum; 2006 Nov; 49(11):1684-91. PubMed ID: 16988851
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
